Published in J Med Chem on January 01, 1984
Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn Schmiedebergs Arch Pharmacol (1987) 2.36
Treatment of hyperthyroidism with sodium iodide I-131. JAMA (1966) 1.93
Scintigraphic localization of pheochromocytoma. N Engl J Med (1981) 1.88
Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation (1990) 1.78
Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med (1985) 1.72
Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med (1980) 1.62
An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. Proc Natl Acad Sci U S A (1996) 1.59
Iodine-125-MIBG to treat neuroblastoma: preliminary report. J Nucl Med (1990) 1.48
PD 115,199: an antagonist ligand for adenosine A2 receptors. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.48
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol (1996) 1.45
Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med (1981) 1.31
Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation (1998) 1.29
Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer. J Nucl Med (1976) 1.26
Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma. J Nucl Med (1987) 1.22
Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med (1981) 1.21
Salivary gland accumulation of meta-[131I]iodobenzylguanidine. J Nucl Med (1984) 1.21
Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol (1988) 1.20
Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med (1987) 1.18
Renal and nephron hemodynamics in spontaneously hypertensive rats. Am J Physiol (1979) 1.17
Treatment of thyroid cancer. Death rates after surgery and after surgery followed by sodium iodide I-131. JAMA (1970) 1.16
Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. Mol Pharmacol (1984) 1.15
Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors. Semin Nucl Med (1985) 1.14
New horizons for therapeutic nuclear medicine in 1981. J Nucl Med (1981) 1.11
Radiopharmaceutical treatment of malignant pheochromocytoma. J Nucl Med (1984) 1.11
Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one. Cancer Res (1987) 1.10
Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med (1997) 1.10
Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nucl Med (1990) 1.07
Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet. Hypertension (1997) 1.07
A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans. J Clin Endocrinol Metab (1977) 1.06
Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine. Ann Intern Med (1981) 1.06
Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. Am J Physiol Imaging (1986) 1.03
Assessment of cardiac sympathetic nerve integrity with positron emission tomography. Nucl Med Biol (2001) 1.01
Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa. Kidney Int (1989) 1.01
Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy. Radiology (1985) 1.01
Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism (1999) 1.01
The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med (1983) 1.00
Radiation dosimetry of 131I-19-iodocholesterol. J Nucl Med (1973) 1.00
Visualizing human malignant melanoma and metastases. Use of chloroquine analog tagged with iodine 125. JAMA (1968) 1.00
Endothelium-derived relaxing factor regulates renin release in vivo. Am J Physiol (1992) 1.00
An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan. J Nucl Med (1984) 0.99
Adrenal scintigraphy. Semin Nucl Med (1978) 0.99
Unusual complications of antithyroid drug therapy: four case reports and review of literature. Thyroidology (1989) 0.99
Alpha-Aminoadipate aminotransferase and kynurenine aminotransferase. Purification, characterization, and further evidence for identity. J Biol Chem (1977) 0.99
Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med (1987) 0.98
[18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses. Synapse (1998) 0.98
Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication. J Nucl Med (1981) 0.98
The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med (1978) 0.97
PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol (1989) 0.97
PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med (1992) 0.97
Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol (1993) 0.97
Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol (1998) 0.96
Angiotensin II: nitric oxide interaction and the distribution of blood flow. Am J Physiol (1993) 0.95
Electrolyte and water balance in young spontaneously hypertensive rats. Hypertension (1983) 0.95
The scintigraphic imaging of endocrine organs. Endocr Rev (1984) 0.95
Response to angiotensin inhibition in rats with sustained renovascular hypertension correlates with response to removing renal artery stenosis. J Vasc Surg (1998) 0.94
Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension. Hypertension (1998) 0.94
Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med (1985) 0.94
Angiotensin dependence of endothelium-mediated renal hemodynamics. Hypertension (1992) 0.94
Evolution of chronic nitric oxide inhibition hypertension: relationship to renal function. Hypertension (1998) 0.93
Renal tubular reabsorption in spontaneously hypertensive rats. Am J Physiol (1979) 0.92
Renal nitric oxide and angiotensin II interaction in renovascular hypertension. Hypertension (1993) 0.92
Correlation of brain scan image and area counting after scanning with tumor pathology. J Nucl Med (1966) 0.92
Diagnosis of adrenal disease by visualization of human adrenal glands with 131 I-19-iodocholesterol. N Engl J Med (1971) 0.91
Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. J Nucl Med (1983) 0.89
Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol (1993) 0.89
Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience. J Nucl Biol Med (1992) 0.89
In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J Nucl Med (1994) 0.89
The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis. Arch Intern Med (1982) 0.89
Evaluation of sympathetic nerve terminals with [(11)C]epinephrine and [(11)C]hydroxyephedrine and positron emission tomography. Circulation (2000) 0.88
Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases. J Nucl Med (1985) 0.88
Myocardial kinetics of carbon-11-meta-hydroxyephedrine: retention mechanisms and effects of norepinephrine. J Nucl Med (1993) 0.88
Radiocholesterol adrenal images for the localization of pheochromocytoma. Surg Gynecol Obstet (1974) 0.88
Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. J Nucl Med (1982) 0.87
Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics. J Hypertens (2000) 0.87
Angiotensin II: endothelium-derived nitric oxide interaction in conscious rats. J Am Soc Nephrol (1994) 0.87
Adrenal imaging with radioiodocholesterol in the diagnosis of adrenal disorders. Adv Intern Med (1974) 0.87
Malignant phaeochromocytoma: clinical, biochemical and scintigraphic characterization. Clin Endocrinol (Oxf) (1984) 0.87
Scintigraphic localization of adrenal lesions in primary aldosteronism. Am J Med (1984) 0.86
Interaction of the prostaglandin and renin-angiotensin systems in isolated rat glomeruli. Am J Physiol (1980) 0.86
Tumor localizing agents. IX. Radioiodinated cholesterol. Steroids (1970) 0.86
Beta-adrenoceptor-stimulated renin release is blunted in old rats. J Am Soc Nephrol (1998) 0.86
Mouse brain distribution of a carbon-11 labeled vesamicol derivative: presynaptic marker of cholinergic neurons. Life Sci (1990) 0.86
In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography. J Cereb Blood Flow Metab (1992) 0.85
High yield synthesis of high specific activity R-(-)-[11C]epinephrine for routine PET studies in humans. Nucl Med Biol (1993) 0.85